GlassScriptPhysician profile
Thomas L Barnes
NPI 1629005798
$948.93
in general payments reported to CMS, 2019-2025
12 companies · $17.79 in 2025
The $17.79 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $63.29 · 2020: $99.13 · 2021: $58.22 · 2022: $335 · 2023: $375 · 2025: $17.79.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $393.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $392.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $350.50 | 2021-2023 | Endurant Iis |
| Musculoskeletal Transplant Foundation INC. | $211.10 | 2019-2023 | |
| Endologix LLC | $149.26 | 2023 | Alto Abdominal Stent Graft System |
| Philips North America LLC | $48.49 | 2023 | |
| Acera Surgical, INC. | $40.80 | 2022 | |
| Abbvie INC. | $38.32 | 2023-2025 | Dalvance |
| Abbott Laboratories | $24.89 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.96 | 2019 | |
| Sanofi-Aventis U.S. LLC | $19.67 | 2022 | |
| Amneal Pharmaceuticals LLC | $19.42 | 2023 | Unithroid |
| Tactile Systems Technology INC | $13.06 | 2022 | |
| Integra Lifesciences Corporation | $12.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Barnes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.